{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:31:37Z","timestamp":1790832697151,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1007\/s11906-001-0065-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T16:48:06Z","timestamp":1180111686000},"page":"S3-S9","source":"Crossref","is-referenced-by-count":47,"title":["Sympathetic overactivity in hypertension: A risk factor for cardiovascular disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Paolo","family":"Palatini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"65_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","volume":"335","author":"S MacMahon","year":"1990","unstructured":"MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease, part I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765\u2013774.","journal-title":"Lancet"},{"key":"65_CR2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.CIR.82.5.1616","volume":"82","author":"Multiple Risk Factor Intervention Trial Research Group","year":"1990","unstructured":"Multiple Risk Factor Intervention Trial Research Group: Mortality after 10 1\/2 years for hypertensive participantes in the Multiple Risk Factor Intervention Trial (dMRFIT). Circulation 1990, 82:1616\u20131628.","journal-title":"Circulation"},{"key":"65_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004872-199715010-00001","volume":"15","author":"P Palatini","year":"1997","unstructured":"Palatini P, Julius S: Heart rate and cardiovascular risk. J Hypertens 1997, 15:1\u201315.","journal-title":"J Hypertens"},{"key":"65_CR4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"R Collins","year":"1990","unstructured":"Collins R, Peto R, MacMahon S, et al.: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827\u2013838.","journal-title":"Lancet"},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","volume":"67","author":"WB Kannel","year":"1967","unstructured":"Kannel WB, Brand N, Skinner JJ Jr, et al.: The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 1967, 67:48\u201359.","journal-title":"Ann Intern Med"},{"key":"65_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.HYP.35.3.807","volume":"35","author":"S Julius","year":"2000","unstructured":"Julius S, Valentini M, Palatini P: Overweight and hypertension: a two-way street? Hypertension 2000, 35:807\u2013813.","journal-title":"Hypertension"},{"key":"65_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004872-199917020-00009","volume":"17","author":"K Narkiewicz","year":"1999","unstructured":"Narkiewicz K, Somers V, Mos L, et al.: An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens 1999, 17:245\u2013249.","journal-title":"J Hypertens"},{"key":"65_CR8","doi-asserted-by":"crossref","first-page":"125S","DOI":"10.1093\/ajh\/2.3.125S","volume":"2","author":"L Landsberg","year":"1989","unstructured":"Landsberg L, Krieger DR: Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989, 2:125S-132S.","journal-title":"Am J Hypertens"},{"key":"65_CR9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.HYP.5.4.584","volume":"5","author":"B Trimarco","year":"1983","unstructured":"Trimarco B, Volpe M, Ricciardelli B, et al.: Studies of the mechanisms underlying impairment of beta-adrenoceptormediated effects in human hypertension. Hypertension 1983, 5:584\u2013590.","journal-title":"Hypertension"},{"key":"65_CR10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cvr\/16.12.732","volume":"16","author":"M Volpe","year":"1982","unstructured":"Volpe M, Trimarco B, Ricciardelli B, et al.: Effects of oral salt loading on beta-adrenergic receptor responsiveness in normal and hypertensive subjects. Cardiovasc Res 1982, 16:732\u2013737.","journal-title":"Cardiovasc Res"},{"key":"65_CR11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/diacare.16.5.828","volume":"16","author":"American Diabetes Association","year":"1993","unstructured":"American Diabetes Association: Detection and management of lipid disorders in diabetes. Diabetes Care 1993, 16:828\u2013834.","journal-title":"Diabetes Care"},{"key":"65_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E","volume":"13","author":"KG Alberti","year":"1996","unstructured":"Alberti KG: The clinical implications of impaired glucose tolerance. Diabet Med 1996, 13:927\u2013937.","journal-title":"Diabet Med"},{"key":"65_CR13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(80)92651-3","volume":"1","author":"JH Fuller","year":"1980","unstructured":"Fuller JH, Shipley MJ, Rose G, et al.: Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980, 1:1373\u20131376.","journal-title":"Lancet"},{"key":"65_CR14","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0021-9150(97)00314-6","volume":"137","author":"M Laakso","year":"1998","unstructured":"Laakso M, Lehto S: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998, 137(suppl):S65-S73.","journal-title":"Atherosclerosis"},{"issue":"suppl 3","key":"65_CR15","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/(SICI)1096-9136(199708)14:3+<S12::AID-DIA439>3.3.CO;2-G","volume":"14","author":"SM Haffner","year":"1997","unstructured":"Haffner SM: Impaired glucose tolerance, insulin resistance and cardiovascular disease. Diabet Med 1997, 14(suppl 3):S12-S18.","journal-title":"Diabet Med"},{"key":"65_CR16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1464-5491.1990.tb01428.x","volume":"7","author":"BM Fisher","year":"1990","unstructured":"Fisher BM, Frier BM: Evidence for a specific heart disease of diabetes in humans. Diabet Med 1990, 7:478\u2013448.","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"65_CR17","first-page":"S1","volume":"23","author":"American Diabetes Association","year":"2000","unstructured":"American Diabetes Association: Clinical practice recommendations 2000. Diabetes Care 2000, 23(suppl 1):S1-S116.","journal-title":"Diabetes Care"},{"key":"65_CR18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755\u20131762.","journal-title":"Lancet"},{"key":"65_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","volume":"340","author":"J Tuomilehto","year":"1999","unstructured":"Tuomilehto J, Rastenyte D, Birkenhager Wh, et al.: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999, 340:677\u2013684.","journal-title":"N Engl J Med"},{"key":"65_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000165747","volume":"31","author":"J Widimsky","year":"1957","unstructured":"Widimsky J, Fejfarova MH, Fejfar Z: Changes of cardiac output in hypertensive disease. Cardiologia 1957, 31:381\u2013389.","journal-title":"Cardiologia"},{"key":"65_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/sim.4780090313","volume":"9","author":"NJ Schork","year":"1990","unstructured":"Schork NJ, Weder AB, Schork MA, et al.: Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med 1990, 9:301\u2013314.","journal-title":"Stat Med"},{"key":"65_CR22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/01.HYP.30.5.1267","volume":"30","author":"P Palatini","year":"1997","unstructured":"Palatini P, Casiglia E, Pauletto P, et al.: Relationship of tachycardia with high blood pressure and metabolic abnormalities. A Study with Mixture Analysis in three Populations. Hypertension 1997, 30:1267\u20131273.","journal-title":"Hypertension"},{"key":"65_CR23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","volume":"125","author":"MW Gillman","year":"1993","unstructured":"Gillman MW, Kannel WB, Belanger A, D\u2018Agostino RB: Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993, 125:1148\u20131154.","journal-title":"Am Heart J"},{"key":"65_CR24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.HYP.33.1.44","volume":"33","author":"A Benetos","year":"1999","unstructured":"Benetos A, Rudnichi A, Thomas F, et al.: Influence of heart rate on mortality in a French population. Role of age, gender, and blood pressure. Hypertension 1999, 33:44\u201352.","journal-title":"Hypertension"},{"key":"65_CR25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI109718","volume":"65","author":"DC Deibert","year":"1980","unstructured":"Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717\u2013721.","journal-title":"J Clin Invest"},{"key":"65_CR26","first-page":"E726","volume":"254","author":"RJ Zeman","year":"1988","unstructured":"Zeman RJ, Ludemann R, Easton TG, Etlinger JD: Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta-2-receptor agonist. Am J Physiol 1988, 254:E726-E732.","journal-title":"Am J Physiol"},{"key":"65_CR27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.HYP.21.5.618","volume":"21","author":"KA Jamerson","year":"1993","unstructured":"Jamerson KA, Julius S, Gudbrandsson T, et al.: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993, 21:618\u2013623.","journal-title":"Hypertension"},{"key":"65_CR28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.HYP.33.3.769","volume":"33","author":"P Palatini","year":"1999","unstructured":"Palatini P, Vriz O, Nesbitt S, et al.: Parental hemodynamic circulation predicts insulin resistance in offspring. The Tecumseh Offspring Study. Hypertension 1999, 33:769\u2013774.","journal-title":"Hypertension"},{"issue":"suppl 1","key":"65_CR29","first-page":"19","volume":"11","author":"P Palatini","year":"1997","unstructured":"Palatini P, Julius S: Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997, 11(suppl 1):19\u201327.","journal-title":"J Hum Hypertens"},{"key":"65_CR30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0026-0495(88)90133-3","volume":"37","author":"SM Haffner","year":"1988","unstructured":"Haffner SM, Fong D, Hazuda HP, et al.: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988, 37:338\u2013345.","journal-title":"Metabolism"},{"key":"65_CR31","first-page":"455","volume":"12","author":"SD Smith","year":"1994","unstructured":"Smith SD, Julius S, Jamerson K, et al.: Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. Hypertension 1994, 12:455\u2013462.","journal-title":"Hypertension"},{"key":"65_CR32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-8703(81)90136-8","volume":"101","author":"PD Sorlie","year":"1981","unstructured":"Sorlie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ: Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J 1981, 101:456\u2013461.","journal-title":"Am Heart J"},{"key":"65_CR33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM196804042781404","volume":"278","author":"RC Tarazi","year":"1968","unstructured":"Tarazi RC, Frohlich ED, Dustan HP: Plasma volume in men with essential hypertension. N Engl J Med 1968, 278:762\u2013765.","journal-title":"N Engl J Med"},{"key":"65_CR34","first-page":"267","volume":"30","author":"JN Cohn","year":"1966","unstructured":"Cohn JN: Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci 1966, 30:267\u2013278.","journal-title":"Clin Sci"},{"key":"65_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","volume":"108","author":"D Levy","year":"1988","unstructured":"Levy D, Anderson KM, Savage DD, et al.: Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988, 108:7\u201313.","journal-title":"Ann Intern Med"},{"key":"65_CR36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(91)90410-M","volume":"68","author":"FR Bauwens","year":"1991","unstructured":"Bauwens FR, Duprez DA, De Buyzere ML, et al.: Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential\/hypertension. Am J Cardiol 1991, 68:925\u2013929.","journal-title":"Am J Cardiol"},{"key":"65_CR37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00004872-200018060-00016","volume":"18","author":"P Palatini","year":"2000","unstructured":"Palatini P, Majahalme S, Nesbitt S, et al.: Determinants of left ventricular mass in young subjects with sympathetic overactivity. The Tecumseh Offspring Study. J Hypertens 2000, 18:769\u2013775.","journal-title":"J Hypertens"},{"key":"65_CR38","first-page":"409","volume-title":"Hypertension","author":"RB Devereux","year":"1995","unstructured":"Devereux RB, Roman MJ: Hypertensive cardiac hypertrophy: Pathophysiologic and clinical characteristics. In Hypertension. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:409\u2013432."},{"key":"65_CR39","first-page":"2367","volume-title":"Hypertension","author":"R Fagard","year":"1995","unstructured":"Fagard R, Amery A: Physical exercise in Hypertension. In Hypertension. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:2367\u20132388."},{"key":"65_CR40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jama.1995.03520290054029","volume":"273","author":"RR Pate","year":"1995","unstructured":"Pate RR, Pratt M, Blair SN, et al.: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995, 273:402\u2013407.","journal-title":"JAMA"},{"key":"65_CR41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.jhh.1001122","volume":"14","author":"PS Sever","year":"2000","unstructured":"Sever-PS, Poulter-NR: Hypertension drug trials: past, present, and future. J Hum Hypertens 2000, 14:729\u2013738.","journal-title":"J Hum Hypertens"},{"key":"65_CR42","first-page":"325","volume":"36","author":"B Davis","year":"2000","unstructured":"Davis B, Furberg CD: Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: interim results. J Am Coll Cardiol 2000, 36:325.","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"65_CR43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199715011-00001","volume":"15","author":"PA Zwieten Van","year":"1997","unstructured":"Van Zwieten PA: Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics. J Hypertens 1997, 15(suppl 1):S3-S8.","journal-title":"J Hypertens"},{"key":"65_CR44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/clpt.1987.185","volume":"42","author":"P Stadler","year":"1987","unstructured":"Stadler P, Leonardi L, Riesen W, et al.: Cardiovascular effects of verapamil in essential hypertension. Clin Pharmacol Ther 1987, 42:85\u201392.","journal-title":"Clin Pharmacol Ther"},{"key":"65_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.HYP.26.1.143","volume":"26","author":"MT Kailasam","year":"1995","unstructured":"Kailasam MT, Parmer RJ, Cervenka JH, et al.: Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995, 26:143\u2013149.","journal-title":"Hypertension"},{"key":"65_CR46","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1248\/bpb.23.1455","volume":"23","author":"Y Mizunuma","year":"2000","unstructured":"Mizunuma Y, Suzuki-Kusaba M, Hisa H, et al.: Participation of angiotensin II in presser response and norepinephrine release to spinal nerve stimulation in pithed rats. Biol Pharmacol Bull 2000, 23:1455\u20131457.","journal-title":"Biol Pharmacol Bull"},{"key":"65_CR47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1358\/dot.2000.36.10.599209","volume":"36","author":"CL Kaul","year":"2000","unstructured":"Kaul CL, Ramarao P: Renin release and the sympathetic nervous system. Drugs Today 2000, 36:699\u2013713.","journal-title":"Drugs Today"},{"issue":"suppl S","key":"65_CR48","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/S0002-8703(99)70317-0","volume":"138","author":"DP Brooks","year":"1999","unstructured":"Brooks DP, Ohlstein EH, Ruffolo RR: Pharmacology of eprosortan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data. Am Heart J 1999, 138(suppl S):S246-S251.","journal-title":"Am Heart J"},{"key":"65_CR49","first-page":"93","volume":"40","author":"DV Preobrazhensky","year":"2000","unstructured":"Preobrazhensky DV, Stepanova OA, Kiktev VG, Shatunova IM: Eprosartan: a novel angiotensin II receptor antagonist with sympathoinhibitory activity. Clinical efficacy and safety in arterial hypertension. Kardiologiya 2000, 40:93\u201399.","journal-title":"Kardiologiya"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-001-0065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-001-0065-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-001-0065-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:16:00Z","timestamp":1559434560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-001-0065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s11906-001-0065-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}